Epigral Ltd vs Neogen Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 856.4 as of 18 Mar 12:28 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Neogen Chemicals Ltd changed from 64.4 on March 2021 to 117.1 on March 2025 . This represents a CAGR of 12.70% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of Neogen Chemicals Ltd changed from ₹ 2016 crore on March 2021 to ₹ 4076 crore on March 2025 . This represents a CAGR of 15.11% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Neogen Chemicals Ltd for the Dec '25 is ₹ 222.22 crore as compare to the Sep '25 revenue of ₹ 210.64 crore. This represent the growth of 5.5% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Neogen Chemicals Ltd for the Dec '25 is ₹ 34.1 crore as compare to the Sep '25 ebitda of ₹ 31.94 crore. This represent the growth of 6.76% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Neogen Chemicals Ltd changed from ₹ 11.47 crore to ₹ 3.69 crore over 7 quarters. This represents a CAGR of -47.69% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Neogen Chemicals Ltd changed from 16.7 % on March 2021 to 5.45 % on March 2025 . This represents a CAGR of -20.07% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Neogen Chemicals Ltd

Neogen Chemicals Limited was incorporated as a Private Limited Company with the name Neogen Chemicals Private Limited' on March 7, 1989 in Thane, Maharashtra.
Subsequently, Company was converted to a Public Limited and the name of the Company was changed to Neogen Chemicals Limited' on July 2, 1998. Neogen is one of India's leading manufacturers of bromine-based compounds, lithium and bromine salts and grignard chemicals.
Specialty chemicals are those chemicals that impart different properties to a variety of products (i.e. the effect that specialty chemicals have varies based on the product) and have a high degree of value addition.
Specialty chemicals are manufactured in smaller volumes when compared to non-specialty chemicals.
Specialty chemicals, including bromine and lithium-based compounds, comprise pharmaceutical intermediates, agrochemical intermediates, engineering fluids, electronic chemicals, polymers additives, water treatment chemicals, construction chemicals and flavours and fragrances.

FAQs for the comparison of Epigral Ltd and Neogen Chemicals Ltd

Which company has a larger market capitalization, Epigral Ltd or Neogen Chemicals Ltd?

Market cap of Epigral Ltd is 3,685 Cr while Market cap of Neogen Chemicals Ltd is 3,585 Cr

What are the key factors driving the stock performance of Epigral Ltd and Neogen Chemicals Ltd?

The stock performance of Epigral Ltd and Neogen Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Neogen Chemicals Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹854.2. On the other hand, Neogen Chemicals Ltd stock price is INR ₹1358.95.

How do dividend payouts of Epigral Ltd and Neogen Chemicals Ltd compare?

To compare the dividend payouts of Epigral Ltd and Neogen Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.